Relationship between Tl-201, Tc-99m (Sn) pyrophosphate and F-18 2-deoxyglucose uptake in ischemically injured dog myocardium. 1987

H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
Department of Radiological Sciences, UCLA School of Medicine 90024.

We have previously demonstrated that enhanced glucose utilization in reperfused myocardium as assessed by F-18 2-deoxyglucose (FDG) and positron tomography predicts functional recovery. In this study, we compared segmental uptake of F-18 FDG with that of Tl-201 and Tc-99m (Sn) pyrophosphate (Tc-99m PPi) as conventional markers of tissue viability in seven dogs after a 3-hour intracoronary balloon occlusion and 20 hours of reperfusion. Myocardial blood flow was determined with microspheres. Regional retention fractions were calculated from tracer tissue concentrations, the arterial input function, and blood flow. Ischemic injury was assessed by triphenyltetrazolium chloride (TTC) staining and histologic analysis. At 24 hours, blood flow was 22% lower in reperfused than in control myocardium (p less than 0.05). Uptake of Tl-201 was related linearly to blood flow (r = 0.92), while glucose utilization and Tc-99m PPi were 2.9 (p less than 0.01) and 4.7 (p less than 0.05) times higher in reperfused than in control myocardium. Retention fractions of Tc-99m PPi increased with the degree of ischemic injury, while F-18 FDG uptake was highest in segments with mild cell injury. Thus, in ischemically injured myocardium, Tl-201 primarily reflects blood flow. F-18 FDG as a marker of glucose utilization identifies ischemically injured but viable tissue. The admixture of necrotic cells can be determined with Tc-99m PPi. Our results indicate that a dual tracer approach might best characterize the presence and extent of reversibly and of irreversibly injured tissue in a given myocardial region.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D011122 Polyphosphates Linear polymers in which orthophosphate residues are linked with energy-rich phosphoanhydride bonds. They are found in plants, animals, and microorganisms. Polyphosphate
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003837 Deoxy Sugars Sugars that in which one or more hydroxyl groups of the pyranose or furanose ring is substituted by hydrogen. Deoxy Sugar,Sugar, Deoxy,Sugars, Deoxy
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005462 Fluorine Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Radioisotopes, Fluorine
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts

Related Publications

H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
July 2003, Clinical nuclear medicine,
H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
July 1992, Clinical nuclear medicine,
H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
February 1996, Clinical nuclear medicine,
H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
April 2008, Clinical nuclear medicine,
H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
December 1992, Clinical nuclear medicine,
H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
May 1991, Journal of molecular and cellular cardiology,
H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
July 2001, Clinical nuclear medicine,
H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
November 1998, Clinical nuclear medicine,
H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
April 2000, Annals of nuclear medicine,
H Sochor, and M Schwaiger, and H R Schelbert, and S C Huang, and D Ellison, and H Hansen, and C Selin, and O Parodi, and M E Phelps
January 1978, European journal of nuclear medicine,
Copied contents to your clipboard!